India, Nov. 3 -- The Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, scheduled for Nov. 4-8, 2026, in Phoenix, Arizona, will showcase new clinical, translational and preclinical data across cancer vaccines, cell therapies, bispecific antibodies, immune checkpoint combinations and next-generation immune-oncology platforms.
The meeting is expected to feature updates from several emerging biotechnology companies developing novel approaches for solid tumors and hematologic malignancies, with investors closely following programs that could support future clinical development, regulatory interactions and value-inflection milestones.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Service...